US Patent Issued to Atea Pharmaceuticals on July 21 for "Advantageous morphic form of AT-527 hemi-sulfate salt" (Massachusetts Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,697, issued on July 21, was assigned to Atea Pharmaceuticals Inc. (Boston).

"Advantageous morphic form of AT-527 hemi-sulfate salt" was invented by Adel Moussa (Burlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Advantageous isolated morphic Form III of the hemi-sulfate salt of AT-527 that exhibits a faster rate of dissolution over the amorphous form leading to increased bioavailability and thus efficacy for therapeutic administration in a solid dosage form to treat viral indications, as well as processes for its manufacture."

The patent was filed on July 25, 2023, under Application No. 18/226,064.

*For further information, including...